Cytotoxicity mechanism of α-MMC in normal liver cells through LRP1 mediated endocytosis and JNK activation

[Display omitted] •α-MMC is more toxic on liver cells than on other normal cells.•α-MMC can bind to membrane receptor and being competitively inhibited by α2-M.•α-MMC can be endocytocesed into liver cells via LRP1 receptor and caused cell apoptosis.•α-MMC could activate the JNK apoptosis signal tran...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Toxicology (Amsterdam) 2016-05, Vol.357-358, p.33-43
Hauptverfasser: Wang, Ling, Shen, Fubing, Zhang, Min, He, Qianchuan, Zhao, Hui, Yu, Xiaoping, Yang, Shuxia, Liu, Yang, Deng, Nianhua, Zheng, Juecun, Zhu, Lixia, Liu, Xiaolan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •α-MMC is more toxic on liver cells than on other normal cells.•α-MMC can bind to membrane receptor and being competitively inhibited by α2-M.•α-MMC can be endocytocesed into liver cells via LRP1 receptor and caused cell apoptosis.•α-MMC could activate the JNK apoptosis signal transduction pathway.•LRP1 knockdown can strongly inhibit the endocytosis of α-MMC and its JNK pathway. Alpha-momorcharin (α-MMC), a type I ribosome-inactivating protein isolated from Momordica charantia, is a potential drug candidate with strong anti-tumor activity. However, α-MMC has a severe hepatotoxicity when applied in vivo, which may greatly hinders its use in clinic in the future. The biological mechanism of hepatotoxicity induced by α-MMC is largely unknown, especially the mechanism by which α-MMC enters the hepatocytes. In this study, we investigated α-MMC-induced cytotoxicity in normal liver L02 cell line as well as the mechanism underlying it. As expected, α-MMC is more toxic in L02 cells than in various normal cells from other organs. The cytotoxic effect of α-MMC on L02 cells is found to be mediated through cell apoptosis as detected by flow cytometry and fluorescence microscopy. Importantly, α-MMC was shown to bind to a specific receptor on cell membrane, as the density of the cell membrane receptor is closely related to both the amount of α-MMC endocytosed and the cytotoxicity in different cell lines. By using LRP1 competitive inhibitor α2-M or siRNA targeting LRP1, we further identified that LRP1 protein served as the membrane receptor for α-MMC. Both α2-M and siRNA targeting LRP1 can significantly inhibit α-MMC’s endocytosis as well as its cytotoxicity in L02 cells. In addition, it was found that α-MMC can activate the JNK signalling pathways via LRP1 in L02 cells. As JNK activation often leads to cell apoptosis, the activation of JNK may play an important role in α-MMC-induced cytotoxicity. To our knowledge, this is the first report showing that LRP1 mediates the cytotoxicity of α-MMC through (1) endocytosis and induced apoptosis and (2) the activation of the JNK pathway. Our findings shed light on the fundamental mechanism of hepatotoxicity of α-MMC and offer reference to understand its mechanism of lymphocytotoxicity and neurotoxicity.
ISSN:0300-483X
1879-3185
DOI:10.1016/j.tox.2016.05.025